What Is GLP-1 Medication Used For?

If you’ve been seeing a flurry of headlines about a new class of injections—semaglutide, tirzepatide, liraglutide, and the like—you're not alone. GLP-1 drugs have become one of the most hyped advances in medicine in decades. For most people, though, the explanation stops at “weight loss drug” or “diabetes shot.” The truth is much more interesting and much more important to understand.

That’s what GLP-1 medications are, what they’re approved for, and the questions you should ask before starting one.

What Does GLP-1 Really Stand For?

GLP-1 is short for glucagon-like peptide-1. It’s a hormone your body makes naturally, mostly in the small intestine, when you eat. When you eat, your gut secretes GLP-1 as part of the normal process of regulating blood sugar and appetite.

This is what this hormone does inside your body:

• Instructs your pancreas to release insulin (the hormone that takes sugar from your blood into your cells) but only when blood sugar is high. Because of this built-in safety mechanism, it doesn’t cause dangerous drops in blood sugar like some older diabetes drugs can.

• This is a process known as gastric emptying; it slows down how quickly food exits the stomach. The food takes longer to digest, and the glucose enters the blood more slowly, with no spikes.

• It talks to appetite centers of the brain—specifically areas that regulate hunger and the feeling of fullness. When GLP-1 goes up, most people feel less hungry.

• BlocIt blocks glucagon, which is a hormone that raises blood sugar. Keeping glucagon in check keeps your glucose levels more stable between meals.

GLP-1 receptor agonists are drugs that mimic this hormone but have one crucial difference—they stay in the body much longer than the GLP-1 your gut naturally produces. Your own GLP-1 breaks down in a matter of minutes. A pharmaceutical version can be active for hours, or even a week, depending on the particular drug.

You end up with a sustained version of what your body already knows how to do, just kept at a level that gives you meaningful clinical outcomes.

Which GLP-1 Medications Are Actually Approved to Treat?

Diabetes Type 2

And this is where the story begins. GLP-1 receptor agonists were initially developed and approved for the treatment of type 2 diabetes. They help control blood sugar and avoid the risk of hypoglycemia that some other agents have. Clinical trials showed they also reduced cardiovascular events—heart attacks and strokes—in people with diabetes who already had a high cardiovascular risk. That discovery altered the wider medical community's opinion about these medications.

Currently approved GLP-1 meds in this category include liraglutide (Victoza), semaglutide (Ozempic), dulaglutide (Trulicity), and others.

Obesity and Weight Loss in the Long Term

Following the cardiovascular and metabolic data from diabetes trials, higher-dose formulations of the same drugs were studied specifically for the purpose of managing weight in people without diabetes. The results were so striking that they each received separate FDA approval.

The FDA approved semaglutide at a higher dose (Wegovy) for chronic weight management in adults who are obese or overweight and have at least one weight-related health condition such as high blood pressure, high cholesterol, or sleep apnea. Tirzepatide (Zepbound) has also been approved in this category, which targets a second related hormone pathway in addition to GLP-1.

These are not approvals for cosmetic weight loss. There are approvals for the medical treatment of obesity, a chronic disease with serious downstream health consequences.

Reduces the risk of heart disease

The FDA approved the use of semaglutide (marketed as Wegovy) in 2024 to reduce the risk of major adverse cardiovascular events—heart attack, stroke, and cardiovascular death—in adults with existing cardiovascular disease who are also overweight or obese. This approval is based on a large clinical trial showing meaningful event reduction independent of weight loss alone.”

This is important because it means that the drug is now considered a cardiovascular drug, not just a metabolic one.

What Research Is Looking at Beyond Current Approvals

Science does not end with approval decisions. Researchers are also studying GLP-1 medications in several other areas. These uses are not yet approved, but they represent real clinical questions:

Chronic Kidney Disease: Early data suggest GLP-1 agonists might slow the progression of kidney disease in people with type 2 diabetes who already have kidney damage.

In 2024, the FLOW trial showed that semaglutide lowered the risk of progressive kidney disease and death from kidney-related causes. Regulators are currently reviewing this data.

Addiction and Substance Use: Observational studies and early trials have found that people taking GLP-1 drugs report fewer cravings—not only for food, but also for alcohol, nicotine, and other substances.

Scientists think it may relate to how the drug affects dopamine pathways in the brain's reward system. Formal clinical trials are in progress.

Cognitive Health and Alzheimer’s Disease The link between metabolic health and brain health is well known. Insulin resistance is associated with a greater risk of Alzheimer's, and some researchers are studying whether the GLP-1 drugs might be protective. Clinical trials are underway, with results expected in the following years.

Non-alcoholic fatty liver disease (NAFLD/MASH): There is information that these medications could decrease liver fat and inflammation, which is a major unmet medical need.

These are areas of research worth knowing about if you have any of these conditions. They are also worth framing properly: Early data are promising but not equivalent to established, approved treatment.

What “Off-Label” Use Means—and Why It Matters to You

An “off-label” prescription is a doctor’s prescription of a drug for a dose or condition that is outside its FDA approval. It sounds like an informal word, but it is a routine, legal, and often well-supported medical practice.

Off-label prescribing accounts for approximately 20% of all prescription drugs in the United States. It is much higher in cancer. Physicians may prescribe approved drugs for unapproved uses, based on their clinical judgment supported by the evidence.

With respect to GLP-1 drugs, off-label use could involve:

• A dose approved for diabetes as a weight-management aid prior to approval of a higher-dose formulation

• Weight management prescribing in a patient who does not meet the strict BMI criteria

• Using a GLP-1 agent to assist with alcohol reduction in a patient with alcohol use disorder

The appropriateness of off-label use is wholly dependent on the quality of the evidence supporting the use, the individual patient’s circumstances, and physician judgment. In many cases, a blanket policy against off-label prescribing would actually harm patients.

What you should do as a patient is ask your doctor, “What is the basis for this off-label prescription? What is the evidence? What are the known risks of this drug? What are the appropriate monitoring parameters?

Who’s a Candidate for GLP-1 Medications?

GLP-1 medications aren't right for everybody. The current guidelines generally support their use for:

• Adults with type 2 diabetes when the goal is to control blood sugar, especially if the goal is also to protect the heart or kidneys

• Adults with a BMI ≥ 30 (the clinical definition of obesity)

• Adults with a BMI of 27 or higher and at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol.

Candidates not suitable for the following:

• Contraindications in prescribing information include patients with a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer) or Multiple Endocrine Neoplasia syndrome type 2.

• Those with a history of pancreatitis, as there is a debate about the association between GLP-1 meds and pancreatic inflammation

• Pregnant or nursing people—these drugs are not currently recommended during pregnancy.

• People with certain gastrointestinal conditions that may be aggravated by slowed gastric emptying

This list is incomplete. Your own medical history is very important, and a complete assessment by a physician who knows your history is required before starting treatment.

Questions to Ask Your Doctor Before Taking a GLP-1 Medication

The best medical conversations are two-way. If your doctor is recommending a GLP-1 medication—or you’re asking about one—these questions will help you make a truly informed decision:

1. I don't prescribe anything. Is the recommendation an approved indication or off-label? What evidence backs up this recommendation in my case?

2. What medication are you recommending, and why this one over others in the same class?

3. What side effects should be expected, especially in the first few weeks? Nausea, vomiting, and gastrointestinal discomfort are very common early on—knowing these symptoms ahead of time helps patients stick through the adjustment period instead of stopping prematurely.”

4. Is this medication meant to be taken long-term? Most of the evidence so far shows that the benefits of weight and metabolism are lost when the medication is discontinued. How long you plan to keep it matters.

5. Are there any medications I am currently taking that could interact with this? Delayed gastric emptying may impact absorption of other oral agents.

6. What should I watch for while taking this medicine? Ongoing management should include regular check-ins, blood work, and assessment of response.

7. What are the alternatives and why this is the right choice for me?

Good clinicians are happy to be asked these questions. If a question feels unwelcome, that’s useful information about your care.

The Last Word:

GLP-1 drugs are truly a paradigm shift in the way medicine tackles metabolic disease. They are not magic, and they have side effects and limitations. But the clinical evidence that has mounted over the past decade supports their use in ways that go meaningfully beyond what most media coverage conveys.

The key is access to accurate, plain-language information, not hype in either direction, for people trying to understand what their doctor has recommended or simply trying to make sense of what they keep reading in the news.

Healthcare Deserved’s content is medically reviewed for accuracy and is based on published medical research. This article is for educational purposes only and is not medical advice. Always check with your doctor before you change any medication or dosage.